A Clinical Study of SPH6516 Tablets in the Treatment of Advanced Solid Tumors.

Clinical trial NCT06266923 · COMPLETED

Trial details

NCT number: NCT06266923
Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2022-01-20
Primary completion: 2023-04-20
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.